Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension

NCT07022730 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-09-18

No results posted yet for this study

Summary

researchers aim to evaluate the influence of prophylactic noradrenaline infusion on post-induction hypotension

Conditions

  • Post Induction Hypotension
  • Sepsis

Interventions

DRUG

Noradrenaline 0.2 mcg/kg/min at 5 minutes before induction

noradrenaline will be given at a rate of 0.2 mcg/kg/min that will start 5 minutes before induction

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-22
Primary Completion
2025-09-17
Completion
2025-09-17

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07022730 on ClinicalTrials.gov